By: | Jun-5-14

<p>The Centers for Medicare &amp; Medicaid Services (CMS) released a bulletin on June 2 announcing that it will not be implementing <a href="">AMP-based Federal Upper Limits</a> (FULs) in July 2014, and that it will be working to finalize guidance on the implementation of the FULs. CMS stated that the guidance will stipulate what the transition period will be. </p>
<p>NACDS and a coalition of stakeholders, recognizing that the time between the issuance of the final rule and the implementation of AMP-based FULs would not give states sufficient time to effectively comply, approached CMS earlier this year urging the agency to implement a transition period.</p>
<p>NACDS then made the issue a priority during its annual <a href="">NACDS RxIMPACT Day on Capitol Hill</a> event in March, where pharmacy advocates participated in 400 congressional meetings and raised the issue with legislators and their staff members.</p>
<p>Following up on the in-person advocacy, a bipartisan group of 49 House members and nine Senators wrote <a href="">letters</a> to Health and Human Services Secretary Kathleen Sibelius urging her to implement the transition period. NACDS Senior Vice President of Government Affairs &amp; Public Policy Carol Kelly said, &ldquo;It made a difference that the pharmacy community was expressing concern about Medicaid beneficiary access.&rdquo;</p>
<p>CMS&rsquo; announcement generated significant media coverage, which NACDS facilitated. To date, articles have appeared in <em>BNA Bloomberg</em>, <em>Inside Health Policy</em> and <em>Congressional Quarterly Healthbeat</em>.</p>
<p>NACDS expressed its appreciation on CMS' announcement in a press <a href="">release </a>on June 2.</p>